Literature DB >> 31223038

Plasma Leptin Does Not Reflect the Effect of High Body Mass Index on Disease Activity in Rheumatoid Arthritis.

Mahdi Taghadosi1, Zahra Samimi2, Shirin Assar3, Mohammad Reza Salahshoor4, Cyrus Jalili5.   

Abstract

Background: The effect of obesity on disease severity in rheumatoid arthritis (RA) remains controversial. Adipocytes secrete pro-inflammatory cytokines and adipokines which may contribute to RA disease activity. The goal of the present study is to address the association between body mass index (BMI) with plasma levels of leptin, pro-inflammatory cytokines, and RA disease severity.
Methods: Fifty RA patients (20 newly diagnosed and 30 under treatment) as well as 30 age- and sex-matched healthy subjects were included in this survey. The plasma levels of leptin and pro-inflammatory cytokines, including TNF-α and IL-6, were measured, and the results were compared among the patients in the three different categories of BMI, including <25, ≥25-30, and ≥30.
Results: In our study, a significant positive correlation was observed between disease activity score-28 (DAS-28) and BMI in overweight (OW) RA patients (p = .036 r = 0.440). The plasma levels of leptin were significantly higher in patients group, compared to healthy subjects (p < .05); moreover, leptin levels were significantly higher in OW and obese patients compared to RA patients with normal BMI (p = .011, p = .001, respectively) and also BMI had positive correlation with leptin concentrations just in the newly diagnosed patients (p < .0001, r = 0.748). There was no correlation between leptin and DAS-28. The plasma IL-6 and TNF-α did not show significant differences between RA patients and healthy subjects, and also the plasma leptin did not have any correlation with plasma levels of IL-6 and TNF-α.
Conclusion: BMI contribution to RA disease severity is independent of systemic levels of leptin and pro-inflammatory cytokines.

Entities:  

Keywords:  Rheumatoid arthritis; body mass index (BMI); disease activity score-28 (DAS-28); leptin; pro-inflammatory cytokines

Mesh:

Substances:

Year:  2019        PMID: 31223038     DOI: 10.1080/08820139.2019.1631844

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  4 in total

1.  Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.

Authors:  Gashaw Dessie
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

2.  Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases.

Authors:  Liberato Giardullo; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Natalia Mansueto; Francesco Paolo Cantatore
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 3.  Breast Cancer and Microcalcifications: An Osteoimmunological Disorder?

Authors:  Alisson Clemenceau; Laetitia Michou; Caroline Diorio; Francine Durocher
Journal:  Int J Mol Sci       Date:  2020-11-15       Impact factor: 5.923

4.  Association of Leptin Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Population.

Authors:  Sha-Sha Tao; Yi-Lin Dan; Guo-Cui Wu; Qin Zhang; Tian-Ping Zhang; Yin-Guang Fan; Hai-Feng Pan
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.